Loading
Ulrik Mouritzen

Ulrik Mouritzen

CEO, Breye Therapeutics
Denmark
Executive Drug Developer with extensive managerial experience building teams and organizational structures to perform effectively and create new medicines for the market, thereby creating value for patients and shareholders. Proven history of successful product development covering early and late-stage development leading to product approvals. More than 20 years R&D experience in a broad range of clinical indications, including immuno-oncology, auto-immune diseases, diabetes, obesity, cardiovascular diseases, and diseases of the endocrine systems. • Extensive experience within leadership, defining strategies for product development and executing clinical programs • Proven ability to translate research data into rational product development and clinical trial designs • Solid experience in building teams and systems that work effectively while motivating teams to engage • Entrepreneurial mindset and a drive to create products that make a difference
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS